Zobrazeno 1 - 10
of 58
pro vyhledávání: '"K E Juhani Airaksinen"'
Autor:
Konsta Teppo, Jussi Jaakkola, Ville L Langén, Fausto Biancari, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Alex Luojus, Juha Hartikainen, K E Juhani Airaksinen, Mika Lehto
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0276612 (2022)
AimsLittle is known about rural-urban differences in the treatment and outcomes in patients with atrial fibrillation (AF). We aimed to assess whether the initiation of oral anticoagulant (OAC) therapy in patients with AF differs between those with ru
Externí odkaz:
https://doaj.org/article/3351c7e576e341afbf77459016544912
Autor:
Jussi Jaakkola, Samuli Jaakkola, K E Juhani Airaksinen, Annastiina Husso, Tatu Juvonen, Mika Laine, Marko Virtanen, Pasi Maaranen, Matti Niemelä, Timo Mäkikallio, Mikko Savontaus, Tuomas Tauriainen, Antti Valtola, Antti Vento, Markku Eskola, Peter Raivio, Fausto Biancari
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0238953 (2020)
Whether the subtype of atrial fibrillation affects outcomes after transcatheter aortic valve replacement for aortic stenosis is unclear. The nationwide FinnValve registry included 2130 patients who underwent primary after transcatheter aortic valve r
Externí odkaz:
https://doaj.org/article/b418b51476fd4e668c4fb53a8d0e2568
Autor:
Samuli Jaakkola, Ilpo Nuotio, Tuomas O Kiviniemi, Raine Virtanen, Melina Issakoff, K E Juhani Airaksinen
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175975 (2017)
Vitamin K antagonist warfarin is widely used in clinical practice and excessive anticoagulation is a well-known complication of this therapy. Little is known about permanent and temporary predictors for severe overanticoagulation. The aim of this stu
Externí odkaz:
https://doaj.org/article/ff8e2b6671a148eb95cd6b6c5c65ca76
Autor:
Jussi Jaakkola, Pirjo Mustonen, Tuomas Kiviniemi, Juha E K Hartikainen, Antti Palomäki, Päivi Hartikainen, Ilpo Nuotio, Antti Ylitalo, K E Juhani Airaksinen
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168010 (2016)
Atrial fibrillation may remain undiagnosed until an ischemic stroke occurs. In this retrospective cohort study we assessed the prevalence of ischemic stroke or transient ischemic attack as the first manifestation of atrial fibrillation in 3,623 patie
Externí odkaz:
https://doaj.org/article/f8ebc1278d254356882d70e5ba910972
Autor:
Heli M Lahtela, Tuomas O Kiviniemi, Marja K Puurunen, Axel Schlitt, Andrea Rubboli, Antti Ylitalo, José Valencia, Gregory Y H Lip, K E Juhani Airaksinen
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128492 (2015)
Renal impairment is a well-known risk factor for cardiovascular complications, but the effect of different stages of renal impairment on thrombotic/thromboembolic and bleeding complications in patients with atrial fibrillation (AF) undergoing percuta
Externí odkaz:
https://doaj.org/article/01123e62b85c4f33bb937f339d701622
Autor:
Nicklas Vinter, Olli Halminen, Mika Lehto, K. E. Juhani Airaksinen, Tomas Andersson, Per Wändell, Martin Holzmann, Ole‐Christian Rutherford, Sigrun Halvorsen, Pia Cordsen, Lars Frost, Søren Paaske Johnsen
Publikováno v:
Vinter, N, Halminen, O, Lehto, M, Airaksinen, K E J, Andersson, T, Wändell, P, Holzmann, M, Rutherford, O-C, Halvorsen, S, Cordsen, P, Frost, L & Johnsen, S P 2023, ' Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway, and Finland ', Basic & Clinical Pharmacology & Toxicology, vol. 133, no. 2, pp. 168-178 . https://doi.org/10.1111/bcpt.13902
Vinter, N, Halminen, O, Lehto, M, Airaksinen, K E J, Andersson, T, Wändell, P, Holzmann, M, Rutherford, O-C, Halvorsen, S, Cordsen, P, Frost, L & Johnsen, S P 2023, ' Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway, and Finland ', Basic & Clinical Pharmacology & Toxicology . https://doi.org/10.1111/bcpt.13902
Vinter, N, Halminen, O, Lehto, M, Airaksinen, K E J, Andersson, T, Wändell, P, Holzmann, M, Rutherford, O-C, Halvorsen, S, Cordsen, P, Frost, L & Johnsen, S P 2023, ' Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway, and Finland ', Basic & Clinical Pharmacology & Toxicology . https://doi.org/10.1111/bcpt.13902
AimTo examine inter-national and regional variations in persistence of oral anticoagulation (OAC) therapy and incidence of clinical outcomes and mortality, among patients with incident atrial fibrillation (AF) in the Nordic countries.MethodsWe conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621048389af5f35b1d890066296c07f8
https://pure.au.dk/portal/da/publications/geographical-variation-in-persistence-to-oral-anticoagulation-therapy-and-clinical-outcomes-among-patients-with-atrial-fibrillation-initiating-therapy-in-denmark-sweden-norway-and-finland(f55eac3a-8901-49b7-8901-c4733d7f51ba).html
https://pure.au.dk/portal/da/publications/geographical-variation-in-persistence-to-oral-anticoagulation-therapy-and-clinical-outcomes-among-patients-with-atrial-fibrillation-initiating-therapy-in-denmark-sweden-norway-and-finland(f55eac3a-8901-49b7-8901-c4733d7f51ba).html
Autor:
Konsta Teppo, K. E. Juhani Airaksinen, Fausto Biancari, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Alex Luojus, Juha Hartikainen, Aapo L. Aro, Mika Lehto
Background Patients with aortic stenosis (AS) have been underrepresented in the trials evaluating direct oral anticoagulants (DOACs) in atrial fibrillation (AF). We aimed to assess whether AS impacts outcomes in patients with AF and estimate the effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca84d1b392f1b81aa32f249fb289791
https://aaltodoc.aalto.fi/handle/123456789/121203
https://aaltodoc.aalto.fi/handle/123456789/121203
Autor:
Konsta Teppo, Jussi Jaakkola, Fausto Biancari, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Juha Hartikainen, K. E. Juhani Airaksinen, Mika Lehto
Funding Information: Konsta Teppo, Jussi Jaakkola, Fausto Biancari and Olli Halminen: none. Jukka Putaala: personal fees from Boehringer‐Ingelheim, personal fees and other from Bayer, grants and personal fees from BMS‐Pfizer, personal fees from P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be71e7cb50260019ce7ecff971f78377
https://aaltodoc.aalto.fi/handle/123456789/118787
https://aaltodoc.aalto.fi/handle/123456789/118787
Autor:
Konsta, Teppo, K E Juhani, Airaksinen, Jussi, Jaakkola, Olli, Halminen, Miika, Linna, Jari, Haukka, Jukka, Putaala, Pirjo, Mustonen, Janne, Kinnunen, Juha, Hartikainen, Aapo L, Aro, Mika, Lehto
Publikováno v:
European heart journal. Quality of careclinical outcomes.
Guidelines on the management of atrial fibrillation (AF) have evolved significantly during the past two decades, but the concurrent developments in real-life management and prognosis of AF are unknown. We assessed trends in the treatment and outcomes
Autor:
Konsta Teppo, K E Juhani Airaksinen, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Juha Hartikainen, Aapo L Aro, Mika Lehto
Publikováno v:
European Heart Journal - Quality of Care and Clinical Outcomes.
Aims Guidelines on the management of atrial fibrillation (AF) have evolved significantly during the past two decades, but the concurrent developments in real-life management and prognosis of AF are unknown. We assessed trends in the treatment and out